Advertisement

Xtant Medical Holdings, Inc. XTNT

Set alert

Price alert · XTNT

All alert types
0.28 USD -0.01 -3.51%

At close · Oct 30

0.29 +0.01 +2.25%

After hours · Oct 30, 4:00 PM ET

Bid
0.28 × 3,000
Ask
0.29 × 200
0.2802 Day range 0.2964
0.28 52-week range 0.92
YTD
-64.08%
1 year
-69.54%
Open
0.281
Prev close
0.2904
Mkt cap
39.31M
Vol
44.52K
Avg vol
1.69M
EPS
-0.08
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2802
High
0.2964
Forward P/E
-13.43
Beta
0.39
Short ratio
6.92
Inst. own
65.12%
Dividend
0.00
Ex-div date
50-d avg
0.467
200-d avg
0.68755
1y target
2.25

2Y chart

Chart tools
Interval

Events in this range
  • Nov 12, 2024Earnings: -0.04; estimate 0; surprise —%
Signals (86)
NameDateAgo
MACD: Sell SignalOct 5, 20263 weeks ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishSep 23, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
SMA: BearishSep 4, 20261 month ago
SMA: BullishSep 2, 20261 month ago
MACD: Buy SignalAug 28, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
RSI: OversoldAug 11, 20262 months ago
MACD: Buy SignalJul 9, 20263 months ago
MACD: Sell SignalJul 8, 20263 months ago
RSI: OversoldJul 8, 20263 months ago
MACD: Buy SignalJul 6, 20263 months ago
MACD: Sell SignalJul 2, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
MACD: Sell SignalJun 25, 20264 months ago
MACD: Buy SignalJun 15, 20264 months ago
MACD: Sell SignalJun 10, 20264 months ago
MACD: Buy SignalJun 4, 20264 months ago
MACD: Sell SignalMay 12, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Buy SignalApr 16, 20266 months ago
RSI: OversoldApr 6, 20266 months ago
MACD: Sell SignalMar 23, 20267 months ago
MACD: Buy SignalMar 20, 20267 months ago
MACD: Sell SignalMar 19, 20267 months ago
SMA: BearishMar 17, 20267 months ago
SMA: BullishMar 16, 20267 months ago
MACD: Buy SignalFeb 10, 20268 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BearishJan 5, 20269 months ago
MACD: Sell SignalJan 5, 20269 months ago
SMA: BullishDec 16, 202510 months ago
SMA: BearishDec 15, 202510 months ago
SMA: BullishDec 12, 202510 months ago
SMA: BearishDec 10, 202510 months ago
SMA: BullishDec 9, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
SMA: BullishDec 5, 202511 months ago
SMA: BearishNov 28, 202511 months ago
SMA: BearishNov 13, 202511 months ago
MACD: Sell SignalNov 4, 202512 months ago
RSI: OverboughtOct 27, 20251 year ago
RSI: OverboughtOct 10, 20251 year ago
MACD: Buy SignalOct 1, 20251 year ago
MACD: Sell SignalSep 26, 20251 year ago
MACD: Buy SignalSep 15, 20251 year ago
SMA: BullishSep 12, 20251 year ago
MACD: Sell SignalSep 4, 20251 year ago
SMA: BullishAug 28, 20251 year ago
SMA: BearishAug 26, 20251 year ago
SMA: BullishAug 21, 20251 year ago
SMA: BearishAug 19, 20251 year ago
SMA: BullishAug 18, 20251 year ago
SMA: BearishAug 15, 20251 year ago
SMA: BullishAug 12, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
SMA: BearishJul 15, 20251 year ago
MACD: Sell SignalJul 11, 20251 year ago
MACD: Buy SignalJul 10, 20251 year ago
MACD: Sell SignalJul 9, 20251 year ago
MACD: Buy SignalJun 30, 20251 year ago
MACD: Sell SignalJun 2, 20251 year ago
RSI: OverboughtMay 22, 20251 year ago
RSI: OverboughtMay 16, 20251 year ago
SMA: BullishMay 5, 20251 year ago
SMA: BearishMay 1, 20251 year ago
SMA: BullishApr 29, 20251 year ago
SMA: BearishApr 28, 20251 year ago
SMA: BullishApr 25, 20251 year ago
MACD: Buy SignalApr 21, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BullishMar 21, 20251 year ago
MACD: Buy SignalMar 20, 20251 year ago
SMA: BearishFeb 27, 20251 year ago
MACD: Sell SignalFeb 11, 20251 year ago
MACD: Buy SignalFeb 10, 20251 year ago
MACD: Sell SignalFeb 7, 20251 year ago
MACD: Buy SignalJan 31, 20251 year ago
MACD: Sell SignalJan 30, 20251 year ago
RSI: OverboughtJan 21, 20251 year ago
RSI: OverboughtJan 3, 20251 year ago

Key statistics

Market cap
56.02M
Enterprise value
99.98M
Trailing P/E
0.00
Forward P/E
-13.43
PEG ratio
0.00
Price / sales
0.50
Price / book
1.02
EPS (TTM)
-0.13
Beta
0.39
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-3.00%
Revenue (TTM)
110.94M
Revenue growth
48.00%
Free cash flow
-28.14M
Total cash
5.38M
Total debt
34.99M
Return on equity
-8.77%
Shares outstanding
139.01M
Short % of float
0.41%
50-day average
0.467
200-day average
0.68755

Analyst view

Consensus: none

Price target (mean) 2.25 +703.0% upside
Target (low)
1.50
Target (mean)
2.25
Target (high)
3.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.02.

Earnings history

Financials — quick view

All financials
XTNT Revenue — quarterly 23.03M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
XTNT Net income — quarterly -9.41M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
XTNT EPS — quarterly -0.07
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

XTNT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 20240.00-0.04——
Aug 8, 2024Jun 1, 20240.00-0.03——
May 15, 2024Mar 1, 20240.00-0.03——
Apr 1, 2024Dec 1, 20230.00-0.03——
Nov 9, 2023Sep 1, 20230.000.07——
Aug 1, 2023Jun 1, 20230.00-0.02——

Upgrades / downgrades

XTNT analyst upgrades and downgrades
DateFirmActionFromTo
May 16, 2024BTIGmainBuyBuy
Dec 5, 2023BTIGinit—Buy
Jul 11, 2023Craig-HallummainBuyBuy
Apr 26, 2023Craig-Halluminit—Buy
May 17, 2019Maxim GroupdownBuyHold
Dec 8, 2016Maxim Groupinit—Buy

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on XTNT — it syncs with the Stock Master app.

Insider holders

XTNT insider holders
InsiderRelationLatest transactionDateShares held
BAKEWELL JOHN KDirectorStock Award(Grant)Aug 14, 2024755,888
BEESON JONN R.DirectorStock Award(Grant)Aug 14, 20241,374,660
BRANDT KEVIN DOfficerStock Award(Grant)Apr 2, 20241,000,070
BROWNE SEAN E.Chief Executive OfficerStock Award(Grant)Apr 2, 20242,306,990
MCNAMARA ROBERT EDirectorStock Award(Grant)Aug 14, 2024754,151
MITCHELL-KELLER LORI DDirectorStock Award(Grant)Aug 14, 2024353,124

Institution ownership

XTNT institution ownership
Holder% heldSharesValueReported
Orbimed Advisors LLC.52.60%73,114,59229.47MSep 29, 2024
Nantahala Capital Management, LLC8.20%11,394,0004.59MSep 29, 2024
Altium Capital Management, LP5.33%7,415,4132.99MSep 29, 2024
Vanguard Group Inc1.55%2,150,912866.82KSep 29, 2024
Juniper Investment Company, LLC0.95%1,318,944531.53KSep 29, 2024
Renaissance Technologies, LLC0.50%694,208279.76KSep 29, 2024

Fund ownership

XTNT fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.03%1,431,435576.87KSep 29, 2024
Vanguard Extended Market Index Fund0.52%719,477289.95KSep 29, 2024
Fidelity Extended Market Index Fund0.21%292,915118.04KOct 30, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.20%279,000112.44KSep 29, 2024
Fidelity Total Market Index Fund0.08%114,33246.08KOct 30, 2024
Fidelity Series Total Market Index Fund0.05%69,34827.95KOct 30, 2024
Advertisement